drugset / Trial / NCT01904097

Functional Neuroimaging in Fibromyalgia Patients Receiving tDCS

NCT01904097

Phase 2 Unknown 34 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate effectiveness and cerebral neuronal ability to adaptation in patients with fibromyalgia who receive pregabalin and transcranial direct current stimulation.

Timeline

Start
2013-03
Primary completion
2014-07
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 150 mg Oral

Indications